![CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure | Infectious Diseases & Immunity CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure | Infectious Diseases & Immunity](https://mednexus.org/cms/10.1097/ID9.0000000000000036/asset/cd130d80-893e-42fd-9d59-963a59a47752/assets/graphic/2096-9511-02-02-009-f002.png)
CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure | Infectious Diseases & Immunity
![Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/74/2/474/F1.large.jpg)
Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases
![JCM | Free Full-Text | Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization JCM | Free Full-Text | Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization](https://pub.mdpi-res.com/jcm/jcm-11-00091/article_deploy/html/images/jcm-11-00091-g001.png?1640659051)
JCM | Free Full-Text | Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
![Tacrolimus Dose Optimization Strategy for Refractory Ulcerative Colitis Based on the Cytochrome P450 3A5 Polymorphism Prediction Using Trough Concentration after 24 Hours | Semantic Scholar Tacrolimus Dose Optimization Strategy for Refractory Ulcerative Colitis Based on the Cytochrome P450 3A5 Polymorphism Prediction Using Trough Concentration after 24 Hours | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4f3b6ce2ef6633481db074b70401a929c74fcd46/5-Figure1-1.png)
Tacrolimus Dose Optimization Strategy for Refractory Ulcerative Colitis Based on the Cytochrome P450 3A5 Polymorphism Prediction Using Trough Concentration after 24 Hours | Semantic Scholar
![The Relationship of Nephrotoxicity to Vancomycin Trough Serum Concentrations in a Veteran's Population: A Retrospective Analysis - Amy Horey, Kari A Mergenhagen, Arun Mattappallil, 2012 The Relationship of Nephrotoxicity to Vancomycin Trough Serum Concentrations in a Veteran's Population: A Retrospective Analysis - Amy Horey, Kari A Mergenhagen, Arun Mattappallil, 2012](https://journals.sagepub.com/cms/10.1345/aph.1R158/asset/images/large/10.1345_aph.1r158-fig1.jpeg)
The Relationship of Nephrotoxicity to Vancomycin Trough Serum Concentrations in a Veteran's Population: A Retrospective Analysis - Amy Horey, Kari A Mergenhagen, Arun Mattappallil, 2012
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis | PLOS ONE
![Frontiers | Monitoring Tacrolimus Trough Concentrations During the First Year After Kidney Transplantation: A National Retrospective Cohort Study Frontiers | Monitoring Tacrolimus Trough Concentrations During the First Year After Kidney Transplantation: A National Retrospective Cohort Study](https://www.frontiersin.org/files/Articles/566638/fphar-11-566638-HTML-r2/image_m/fphar-11-566638-g001.jpg)
Frontiers | Monitoring Tacrolimus Trough Concentrations During the First Year After Kidney Transplantation: A National Retrospective Cohort Study
![Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn's disease: a Chinese real-world study | BMC Gastroenterology | Full Text Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn's disease: a Chinese real-world study | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12876-021-01946-8/MediaObjects/12876_2021_1946_Fig3_HTML.png)
Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn's disease: a Chinese real-world study | BMC Gastroenterology | Full Text
![Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST | SpringerLink Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10147-023-02325-x/MediaObjects/10147_2023_2325_Fig4_HTML.png)
Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST | SpringerLink
![Performance of a Divided-Load Intravenous Vancomycin Dosing Strategy for Obese Patients - Tina Harrach Denetclaw, Mark Kevin Yu, Mee Moua, Thomas C. Dowling, Douglas Steinke, 2015 Performance of a Divided-Load Intravenous Vancomycin Dosing Strategy for Obese Patients - Tina Harrach Denetclaw, Mark Kevin Yu, Mee Moua, Thomas C. Dowling, Douglas Steinke, 2015](https://journals.sagepub.com/cms/10.1177/1060028015586423/asset/images/large/10.1177_1060028015586423-fig4.jpeg)
Performance of a Divided-Load Intravenous Vancomycin Dosing Strategy for Obese Patients - Tina Harrach Denetclaw, Mark Kevin Yu, Mee Moua, Thomas C. Dowling, Douglas Steinke, 2015
![Comparison of D-dimer values at peak and trough concentrations of direct oral anticoagulants: result of D-dimer testing is not affected by plasma drug concentration - ISTH Congress Abstracts Comparison of D-dimer values at peak and trough concentrations of direct oral anticoagulants: result of D-dimer testing is not affected by plasma drug concentration - ISTH Congress Abstracts](https://abstracts.isth.org/wp-content/uploads/2021/06/311_results_1.jpg)
Comparison of D-dimer values at peak and trough concentrations of direct oral anticoagulants: result of D-dimer testing is not affected by plasma drug concentration - ISTH Congress Abstracts
![Trough concentration may not be a good target for polymyxin B therapeutic drug monitoring | Critical Care | Full Text Trough concentration may not be a good target for polymyxin B therapeutic drug monitoring | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-023-04326-8/MediaObjects/13054_2023_4326_Fig1_HTML.png)
Trough concentration may not be a good target for polymyxin B therapeutic drug monitoring | Critical Care | Full Text
![Candidates for area under the concentration–time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients - ScienceDirect Candidates for area under the concentration–time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213716521001880-ga2.jpg)
Candidates for area under the concentration–time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients - ScienceDirect
![Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit - ScienceDirect Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1201971217301303-gr2.jpg)